rm-493 has been researched along with Progeria* in 1 studies
1 other study(ies) available for rm-493 and Progeria
Article | Year |
---|---|
New Drugs for Rare Disorders.
Several new drugs have been approved to treat rare genetic disorders: setmelanotide for certain conditions causing obesity; lumasiran for primary hyperoxaluria type 1, a kidney disorder; and lonafarnib for two diseases that cause premature aging. Topics: alpha-MSH; Anti-Obesity Agents; Humans; Piperidines; Progeria; Pyridines; Rare Diseases | 2021 |